Manuela Cabiati; Melania Gaggini; Maria Michela Cesare; Chiara Caselli; Paolo De Simone; Franco Filipponi; Giuseppina Basta; Amalia Gastaldelli; Silvia Del Ry

An updated overview on hepatocellular carcinoma in patients with Metabolic dysfunction-Associated Steatotic Liver Disease: Trends, pathophysiology and risk-based surveillance

Metabolism 162 (2025)

Angelo Armandi; Chiara Rosso; Gian Paolo Caviglia; Elisabetta Bugianesi

Serum osteopontin as a blood biomarker in relapsing–remitting multiple sclerosis Egyptian patients

The Egyptian Journal of Laboratory Medicine 33(1) (2021)

Dina L. Mohamed; Hanaa A. Amer; Rania A. Aboshady; Mohamed A. Abdel Hafeez; Neama M. Lotfy

The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis

PLOS ONE 15(2) (2020)

Jiaxin Zhang; Guang Chen; Peng Zhang; Jiaying Zhang; Xiaoke Li; Da’nan Gan; Xu Cao; Mei Han; Hongbo Du; Yong’an Ye

Osteopontin versus alpha-fetoprotein as a diagnostic marker for hepatocellular carcinoma: a meta-analysis

OncoTargets and Therapy Volume 11 (2018)

Tingting Sun; Yurong Tang; Diwen Sun; Qingao Bu; Peng Li

Diagnostic accuracy of osteopontin plus alpha-fetoprotein in the hepatocellular carcinoma: A meta-analysis

Clinics and Research in Hepatology and Gastroenterology 41(5) (2017)

Jinwan Li; Xiaoli Chen; Meiyu Dai; Shifeng Huang; Jingfan Chen; Shengming Dai

Proteomic Profiling and Artificial Intelligence for Hepatocellular Carcinoma Translational Medicine

Biomedicines 9(2) (2021)

Nurbubu Moldogazieva; Innokenty Mokhosoev; Sergey Zavadskiy; Alexander Terentiev

Serum osteopontin predicts glycaemic profile improvement in metabolic syndrome: A pilot study

European Journal of Clinical Investigation 51(3) (2020)

Lara Caserza; Matteo Casula; Edorado Elia; Aldo Bonaventura; Luca Liberale; Maria Bertolotto; Nathan Artom; Silvia Minetti; Paola Contini; Daniela Verzola; Roberto Pontremoli; Franesca Viazzi; Giorgio L. Viviani; Stefano Bertolini; Aldo Pende; Livia Pisciotta; Fabrizio Montecucco; Federico Carbone

Suppression of osteopontin inhibits chemically induced hepatic carcinogenesis by induction of apoptosis in mice

Oncotarget 7(52) (2016)

Su-Hyung Lee; Jun-Won Park; Sang-Ho Woo; Du-Min Go; Hyo-Jung Kwon; Ja-June Jang; Dae-Yong Kim

Biomarker development for hepatocellular carcinoma early detection: current and future perspectives

Hepatic Oncology 4(4) (2017)

Shreya Sengupta; Neehar D Parikh

Performance of SPINK1 and SPINK1‐based diagnostic model in detection of hepatocellular carcinoma

Journal of Clinical Laboratory Analysis 35(11) (2021)

Fang Wang; Hui Liu; Youxi Bai; Hui Li; Zhonglin Wang; Xin Xu

Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease

Cochrane Database of Systematic Reviews 2021(4) (2021)

Agostino Colli; Tin Nadarevic; Damir Miletic; Vanja Giljaca; Mirella Fraquelli; Davor Štimac; Giovanni Casazza

A Study on the Serum γ-Glutamyltranspeptidase and Plasma Osteopontin in Alcoholic Liver Disease

Journal of Laboratory Physicians 14(02) (2021)

Arpita Suri; Naveen Singh; Sanjiv Kumar Bansal

Novel Mechanism of Nonalcoholic Lipid Accumulation Promoting Malignant Transformation of Hepatocytes

Neoplasm (2018)

Min Yao; Wenjie Zheng; Li Wang; Miao Fang; Zhizhen Dong; Dengfu Yao

Biomarkers for Hepatocellular Carcinoma: From Origin to Clinical Diagnosis

Biomedicines 11(7) (2023)

Mona A. Omar; Mohamed M. Omran; Khaled Farid; Ashraf A. Tabll; Yasser E. Shahein; Tarek M. Emran; Ana Petrovic; Nikola R. Lucic; Robert Smolic; Tanja Kovac; Martina Smolic

A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma

Frontiers in Oncology 13 (2023)

Ti Yang; Yurong Luo; Junhao Liu; Fang Liu; Zengxin Ma; Gai Liu; Hailiang LI; Jianfan Wen; Chengcong Chen; Xiancheng Zeng

Biomarkers for Hepatocellular Carcinoma

Biomarkers in Cancer 9 (2017)

Jiatao Lou; LingFei Zhang; Shaogang Lv; Chenzi Zhang; Shuai Jiang

Discovery of a Potential Plasma Protein Biomarker Panel for Acute-on-Chronic Liver Failure Induced by Hepatitis B Virus

Frontiers in Physiology 8 (2017)

Ni Zhou; Kuifeng Wang; Shanhua Fang; Xiaoyu Zhao; Tingting Huang; Huazhong Chen; Fei Yan; Yongzhi Tang; Hu Zhou; Jiansheng Zhu

Significance of biglycan and osteopontin as non-invasive markers of liver fibrosis in patients with chronic hepatitis B virus and chronic hepatitis C virus

Journal of Investigative Medicine 67(3) (2019)

Ali Sobhy; Fakhry M. Mohammed; A Azeem Haitham; Ahmed M Ashmawy; Hamed Omar Khalifa

Diagnostic accuracy and prognostic significance of osteopontin in liver cirrhosis and hepatocellular carcinoma: a Meta-analysis

Biomarkers 27(1) (2021)

Yingshi Zhang; Jiayue Gao; Yu Bao; Yang Liu; Yimeng Tong; Shuqing Jin; Qingchun Zhao

Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma

Royal Society Open Science 5(12) (2018)

Otília Menyhárt; Ádám Nagy; Balázs Győrffy